I think it's a good progress. FDA is unsure if the current trial protocol will be enough to generate all the possible data.
The fact that the FDA believes that ATL1102 may be a better treatment option and working in partnership with ANP sounds good to me...
Matter of time and FTD is given for ID
Very important small steps moving forward..now come on MD tell us where are you getting the money from..lol
Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-4
-
- There are more pages in this discussion • 171 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
